Common Contracts
109 similar Common Stock Purchase Agreement contracts by Athersys, Inc / New, Novan, Inc., Ocean Power Technologies, Inc., others
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • May 12th, 2022 • Athersys, Inc / New • Pharmaceutical preparations • Illinois
COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of May 12, 2022, by and between ATHERSYS, INC., a Delaware corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • June 25th, 2021 • Athersys, Inc / New • Pharmaceutical preparations • Illinois
COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of June 24, 2021, by and between ATHERSYS, INC., a Delaware corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • October 16th, 2020 • X4 Pharmaceuticals, Inc • Biological products, (no disgnostic substances) • Illinois
COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of October 14, 2020, by and between X4 PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • September 18th, 2020 • Ocean Power Technologies, Inc. • Electric services • Illinois
COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of September 18, 2020, by and between OCEAN POWER TECHNOLOGIES, INC., a Delaware corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • September 14th, 2020 • aTYR PHARMA INC • Biological products, (no disgnostic substances) • Illinois
COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of September 11, 2020, by and between ATYR PHARMA, INC., a Delaware corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • August 4th, 2020 • Innovation Pharmaceuticals Inc. • Pharmaceutical preparations • Nevada
This COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), is dated as of July 31, 2020 by and between INNOVATION PHARMACEUTICALS INC., a Nevada corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”).Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • July 22nd, 2020 • Novan, Inc. • Pharmaceutical preparations • Illinois
COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of July 21, 2020 by and between NOVAN, INC., a Delaware corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • June 26th, 2020 • Veru Inc. • Pharmaceutical preparations • Illinois
COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of June 26, 2020 by and between VERU INC., a Wisconsin corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • June 17th, 2020 • Novan, Inc. • Pharmaceutical preparations • Illinois
COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of June 15, 2020 by and between NOVAN, INC., a Delaware corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • April 13th, 2020 • Scynexis Inc • Pharmaceutical preparations • Illinois
COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of April 10, 2020 by and between SCYNEXIS, INC., a Delaware corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • March 4th, 2020 • Remark Holdings, Inc. • Communications services, nec • Illinois
COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of March 3, 2020 by and between REMARK HOLDINGS, INC., a Delaware corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • March 2nd, 2020 • Marker Therapeutics, Inc. • Pharmaceutical preparations • Illinois
COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of February 28, 2020 by and between MARKER THERAPEUTICS, INC., a Delaware corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • February 27th, 2020 • Curis Inc • Biological products, (no disgnostic substances) • Illinois
COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of February 26, 2020 by and between CURIS, INC., a Delaware corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • February 11th, 2020 • Sorrento Therapeutics, Inc. • Biological products, (no disgnostic substances) • Illinois
COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of February 10, 2020 by and between Sorrento Therapeutics, Inc., a Delaware corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • December 11th, 2019 • Miragen Therapeutics, Inc. • Services-medical laboratories • Illinois
COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of December 11, 2019 by and between MIRAGEN THERAPEUTICS, INC., a Delaware corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • November 6th, 2019 • Athersys, Inc / New • Pharmaceutical preparations • Illinois
COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of November 5, 2019, by and between ATHERSYS, INC., a Delaware corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • October 28th, 2019 • Salarius Pharmaceuticals, Inc. • Pharmaceutical preparations • Illinois
COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of October 24, 2019 by and between SALARIUS PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • October 28th, 2019 • Celsion CORP • Pharmaceutical preparations • Illinois
COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of October 28, 2019, by and between CELSION CORPORATION, a Delaware corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • October 25th, 2019 • Ocean Power Technologies, Inc. • Electric services • Illinois
COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of October 24, 2019, by and between OCEAN POWER TECHNOLOGIES, INC., a Delaware corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • October 21st, 2019 • Tracon Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Illinois
COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of October 18, 2019, by and between TRACON PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • October 21st, 2019 • Entasis Therapeutics Holdings Inc. • Pharmaceutical preparations • Illinois
COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of October 21, 2019 by and between ENTASIS THERAPEUTICS HOLDINGS INC., a Delaware corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • September 5th, 2019 • Novan, Inc. • Pharmaceutical preparations • Illinois
COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of August 30, 2019, by and between NOVAN, INC., a Delaware corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • July 30th, 2019 • PDS Biotechnology Corp • Pharmaceutical preparations • Illinois
COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of July 29, 2019, by and between PDS BIOTECHNOLOGY CORPORATION, a Delaware corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
AMENDED AND RESTATED COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • July 24th, 2019 • Ritter Pharmaceuticals Inc • Pharmaceutical preparations • Illinois
This AMENDED AND RESTATED COMMON STOCK PURCHASE AGREEMENT (the “Agreement”) is entered into as of July 23, 2019, by and between RITTER PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). This Agreement hereby amends and restates the Common Stock Purchase Agreement entered into between the parties as of May 4, 2017, as amended and restated as of March 29, 2019. Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
AMENDED AND RESTATED COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • July 24th, 2019 • Ritter Pharmaceuticals Inc • Pharmaceutical preparations • Illinois
This AMENDED AND RESTATED COMMON STOCK PURCHASE AGREEMENT (the “Agreement”) is entered into as of July 23, 2019, by and between RITTER PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). This Agreement hereby amends and restates the Common Stock Purchase Agreement entered into between the parties as of May 4, 2017, as amended and restated as of March 29, 2019. Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • April 5th, 2019 • Remark Holdings, Inc. • Communications services, nec • Illinois
COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of March 29, 2019 by and between REMARK HOLDINGS, INC., a Delaware corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • March 29th, 2019 • ONCOSEC MEDICAL Inc • Pharmaceutical preparations • Nevada
COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of March 29, 2019 by and between ONCOSEC MEDICAL INCORPORATED, a Nevada corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • March 14th, 2019 • Bionano Genomics, Inc • Laboratory analytical instruments • Illinois
COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of March 14, 2019, by and between BIONANO GENOMICS, INC., a Delaware corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • February 19th, 2019 • Recro Pharma, Inc. • Pharmaceutical preparations • Illinois
COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of February 19, 2019, by and between RECRO PHARMA, INC., a Pennsylvania corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • August 13th, 2018 • Ocean Power Technologies, Inc. • Electric services • Illinois
COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of August 13, 2018, by and between OCEAN POWER TECHNOLOGIES, INC., a Delaware corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • July 3rd, 2018 • Remark Holdings, Inc. • Communications services, nec • Illinois
COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of July 2, 2018 by and between REMARK HOLDINGS, INC., a Delaware corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • June 25th, 2018 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • Illinois
COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of June 25, 2018 by and between SUNESIS PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • June 20th, 2018 • Valeritas Holdings Inc. • Surgical & medical instruments & apparatus • Illinois
COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of June 11, 2018, by and between VALERITAS HOLDINGS, INC., a Delaware corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • May 18th, 2018 • MYnd Analytics, Inc. • Services-misc health & allied services, nec • Illinois
COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of May 15, 2018, by and between MYND ANALYTICS, INC., a Delaware corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • March 2nd, 2018 • Recro Pharma, Inc. • Pharmaceutical preparations • Illinois
COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of March 2, 2018, by and between RECRO PHARMA, INC., a Pennsylvania corporation (the “Company”), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the “Buyer”). Capitalized terms used herein and not otherwise defined herein are defined in Section 10 hereof.
